Humana Inc. (NYSE:HUM) is FNY Investment Advisers LLC’s 2nd Largest Position

FNY Investment Advisers LLC boosted its stake in shares of Humana Inc. (NYSE:HUM) by 6,647.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 27,260 shares of the insurance provider’s stock after purchasing an additional 26,856 shares during the period. Humana makes up about 3.6% of FNY Investment Advisers LLC’s portfolio, making the stock its 2nd biggest position. FNY Investment Advisers LLC’s holdings in Humana were worth $6,916,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Marshall Wace LLP raised its stake in Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after acquiring an additional 774,085 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after purchasing an additional 738,701 shares during the period. FMR LLC raised its stake in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Baupost Group LLC MA acquired a new stake in shares of Humana during the second quarter worth about $156,933,000. Finally, Thrivent Financial for Lutherans boosted its position in Humana by 639.8% in the second quarter. Thrivent Financial for Lutherans now owns 385,782 shares of the insurance provider’s stock valued at $144,147,000 after buying an additional 333,636 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Wells Fargo & Company decreased their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $392.00 to $274.00 in a research report on Thursday, October 3rd. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and boosted their price objective for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Finally, Stephens reaffirmed an “equal weight” rating and set a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $302.00.

Humana Stock Up 6.9 %

Shares of HUM opened at $287.48 on Tuesday. The stock has a 50 day moving average price of $273.89 and a 200 day moving average price of $309.74. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $34.62 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 2.12 and a beta of 0.55. Humana Inc. has a one year low of $213.31 and a one year high of $455.53.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts forecast that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.23%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.